Alzheimer's is much more complicated in this regard. We do have biomarkers, like I said a second ago, right? We have amyloid, we have tau. Historically, and for the purposes of research, these were typically drawn from CSF. The C2N developed amyloid score uses a couple of things. It takes ApoE status, AB 40 to 42 ratio, as measured in the plasma,. And then it predicts the probability of AD pathology.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode